Welcome to our website!

Product Catalog

Rapid Product Index

Recommended Products

Friend Links

Your Location:Home>News Center

FDA Approves Fulphila

FDA Approves Fulphila U.S. FDA Approves Fulphila (pegfilgrastim-jmdb), the First Biosimilar to Neulasta HERTFORDSHIRE, England and PITTSBURGH and BENGALURU, India, June 4, 2018 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) and Biocon Ltd. (BSE code: 532523,

Patients on Opioids OK With Lower Doses

Patients on Opioids OK With Lower Doses FRIDAY, June 8, 2018 -- Even patients who have taken high doses of opioid painkillers for long periods of time arent unhappy with their care when their doctor lowers their dose, new research suggests. The study

Noninvasive Blood Test Can Predict Gestational Age

Noninvasive Blood Test Can Predict Gestational Age FRIDAY, June 8, 2018 -- Noninvasive blood tests can predict gestational age and can identify women at risk for preterm delivery using cell-free RNA, according to a study published in the June 8 issue of

Cryoablation Efficacious for Cancer Pain, Review Finds

Cryoablation Efficacious for Cancer Pain, Review Finds WEDNESDAY, May 23, 2018 -- Cryoablation is effective for controlling cancer pain without many side effects, according to a review published online May 7 in PAIN Practice. Laura Ferrer-Mileo, from

FDA Approves Yonsa

FDA Approves Yonsa Sun Pharma Announces FDA Approval of Yonsa (abiraterone acetate) to Treat Metastatic Castration-Resistant Prostate Cancer MUMBAI & PRINCETON, N.J. & KING OF PRUSSIA, Pa. May 23, 2018 --(BUSINESS WIRE)--Sun Pharmaceutical Industries Lt